HSANZ Free Communications 11: Pre-clinical cell biology and novel diagnostic approaches
Tracks
HSANZ
| Tuesday, October 20, 2026 |
| 2:00 PM - 3:30 PM |
Speaker
Dr Aroonima Misra
Scientist
Indian Council Of Medical Research
Novel dried blood spots protocol enable qualitative fusion transcript detection in leukemia: proof-of-concept validation with long-term frozen biobanking
2:00 PM - 2:15 PM
Ms Tamia Nguyen
Medical Scientist/phd Candidate
Peter MacCallum Cancer Centre
Next-generation-sequencing-based UBTF tandem duplication measurable residual disease (UBTF-MRD) in patients with MDS and AML
2:15 PM - 2:30 PM
Dr Aditya Tedjaseputra
Molecular Haematologist
King's College London
Post-induction MRD in NPM1 AML by molecular methods: a cross-validation ultra-sensitive NGS vs. RT-qPCR study from the UK NCRI AML17 trial
2:30 PM - 2:45 PM
Prof Sanjeev Kumar Gupta
Professor
All India Institute of Medical Sciences (AIIMS) New Delhi
Role of whole transcriptome sequencing and artificial intelligence in subtyping of B-cell acute lymphoblastic leukemia (B-ALL) in an Indian cohort
2:45 PM - 3:00 PM
Mrs Maha Kamel
Phd Candidate
Adelaide University
TET2 Loss in human monocytes and macrophages drives inflammasome activation and promotes clonal expansion in CMML
3:00 PM - 3:15 PM
Ms Sarah Clarke
Phd Student
University of Western Australia
Multiparametric immuno-flowFISH enables sensitive detection of IGH rearrangements in multiple myeloma without plasma cell enrichment
3:15 PM - 3:30 PM
